Company completed 28 consecutive trading days above $1.00 per share on June 25, 2026 Reverse stock split effectuated to ...
Detailed price information for Hcw Biologics Inc (HCWB-Q) from The Globe and Mail including charting and trades.
HCW Biologics Inc. HCWB stock fell during Tuesday’s session. The company announced preliminary results from its Phase 1 trial for HCW9302, an IL-2-based treatment for alopecia areata. All participants ...
Company now compliant with all continued listing rules for NasdaqMIRAMAR, Fla., June 30, 2026 (GLOBE NEWSWIRE) -- HCW ...
Detailed price information for Hcw Biologics Inc (HCWB-Q) from The Globe and Mail including charting and trades.
HCW Biologics Inc. (NASDAQ:HCWB) shares were up Monday after the company announced a breakthrough in developing second-generation pembrolizumab-based immunotherapies for solid tumors. What to Know: ...
Cytokine-Based Fusion Proteins to Activate and Expand Memory-Like NK Cells Without Using Feeder CellsSufficient for Off-the-Shelf Multi-Dose Adoptive Cell Therapy Cytokine-Based Fusion Proteins to ...
HCW Biologics, Inc. (NASDAQ:HCWB) shares are trading higher on Monday after the company announced clearance from the Food and Drug Administration (FDA) for its Phase 1 trial of HCW9302. The Details: ...
It's easy to feel disappointed if you buy a stock that goes down. But often it is not a reflection of the fundamental business performance. The HCW Biologics Inc. (NASDAQ:HCWB) share price is down 15% ...
MIRAMAR, Fla., March 02, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the "Company” or "HCW Biologics”) (Nasdaq: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing ...
Potentially best-in-class IL-2 based treatment for autoimmune diseases by expanding and activating regulatory T cells Readout for dose-escalating clinical study for first two dose cohorts All ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results